Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 1601 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Erytech–Infopro Digital: investor conference, 201811 supply service Erytech at Actionaria 2018 in Paris 2018-11-22
Erytech–Leucadia: investor conference, 201811 supply service Erytech at Jefferies London Healthcare Conference 2018 2018-11-14
Sanofi–Denali Therapeutics: RIPK1 inhibitors, 201811– collab $125m upfront + >$1b + royalties RIPK1 inhibitors incl DNL 747 + DNL 758 2018-11-01
Magnisense–SEVERAL: investment, 201810 financing round €5m from new + existing investors incl Meusinvest + Provestis + Concorde Capital + Minv 2018-10-24
Microbiotica–BPCE: investment, 201810 investment £4m by Seventure Partners’ Health for Life Capital Fund 2018-10-24
Acticor Biotech–CapDecisif: investment, 201810 financing round Series B totalling €15.3m incl existing + co-investor CapDecisif Management (HK) 2018-10-17
Acticor Biotech–China Medical System: investment, 201810 financing round Series B totalling €15.3m incl new + co-investor CMS Medical Venture 2018-10-17
Acticor Biotech–Mirae Asset: investment, 201810 financing round Series B totalling €15.3m incl new + co-investor Mirae Asset Capital Co Ltd 2018-10-17
Acticor Biotech–NewCap: public relations, 201810 service existent by NewCap 2018-10-17
Acticor Biotech–Newton Biocapital: investment, 201810 financing round Series B totalling €15.3m incl new + lead investor Newton Biocapital 2018-10-17
Acticor Biotech–PERSON: investment, 201810 financing round Series B totalling €15.3m incl new + co-investor A&B (HK) 2018-10-17
Acticor Biotech–SEVERAL: investment, 201810 financing round Series B €15.3m led by new investor Newton Biocapital 2018-10-17
Erytech–EZIL: investor conference, 201810 supply service Erytech at European Large & Midcap Event in Paris 2018-10-09
Rgenix–SEVERAL: investment, 201810 financing round Series C $40m led by Lepu Medical + incl Novo Holdings + Sofinnova Partners et al 2018-10-09
Sanofi–Evotec: drug discovery, 201810– collab partnership BRIDGE LAB031 for early-stage projects out of academic research 2018-10-04
Sartorius–Genedata: bioinformatics, 201810 collab product integration of Genedata Bioprocess s/w with ambr mini bioreactos 2018-10-02
JSTI Group–Eurofins: investment, 201810– acquisition $175m cash+debt free of TestAmerica by Eurofins from JSTI Group (CN) 2018-10-01
Sanofi–Advent International: investment, 201804–201810 acquisition €1.9b (enterprise value) of Sanofi’s European generics business Zentiva by Advent 2018-10-01
Genewiz–Brooks Automation: investment, 201809– acquisition $450m of Genewiz by Brooks ANNOUNCED 2018-09-26
Minoryx–SEVERAL: investment, 201809 financing round Series B €21.3m led by Fund+ with SFPI + SRIW + Sambrinvest + all Series A investors 2018-09-26
Valneva–SEVERAL: investment, 201809 private placement €50m with 13.33m new ordinary shares at €3.75/share led by US healthcare investors 2018-09-26
Axenis–genOway: investment, 201809 acquisition of Axenis SAS by genOway SA 2018-09-25
GeNeuro–Servier: investment, 201809 existent investor Servier 2018-09-18
Horama–V-Bio Ventures: investment, 201809 Series B investment €3.5m by V-Bio bringing total Series B round to €22.5m 2018-09-18
GamaMabs Pharma–Andrew Lloyd Associates: public relations, 201809 service existent by ALA 2018-09-17
Applied Microarrays–Novacyt: DNA microarrays, 201809– €na collab developm probes for customised SNP microarrys by Primerdesign 2018-09-13
Erytech–Morgan Stanley: investor conference, 201809 supply service Erytech presents at Morgan Stanley Global Healthcare Conference NY 2018-09-13
Celgene–Evotec: drug discovery services, 201809– strategic RnD collab in field of targeted protein degradation using Panomics platform 2018-09-06
Genkyotex–Yorkville Group: credit, 201808– up to €7.5m convertible notes with attached warrants in 2 tranches with YA II PN Ltd 2018-08-20
Artios Pharma–AbbVie: investment, 201808 financing round Series B totalling $84m incl existing + co-investor AbbVie Ventures 2018-08-10
Artios Pharma–Andera Partners: investment, 201808 financing round Series B totalling $84m (£65m) incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Arix Bioscience: investment, 201808 financing round Series B totalling $84m incl existing + co-investor Arix Bioscience 2018-08-10
Artios Pharma–IP Group: investment, 201808 financing round Series B totalling $84m incl existing + co-investor IP Group 2018-08-10
Artios Pharma–Life Sciences Partners: investment, 201808 financing round Series B totalling $84m incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Merck (DE): investment, 201808 financing round Series B totalling $84m incl existing + co-investor M Ventures 2018-08-10
Artios Pharma–Novartis: investment, 201808 financing round Series B totalling $84m incl new + co-investor Novartis Venture Fund 2018-08-10
Artios Pharma–Pfizer: investment, 201808 financing round Series B totalling $84m incl new + co-investor Pfizer Ventures 2018-08-10
Artios Pharma–SEVERAL: investment, 201808 financing round Series B $84m (£65m) led by new investors Andera Partners + LSP 2018-08-10
Artios Pharma–SV Health Investors: investment, 201808 financing round Series B totalling $84m incl existing + co-investor SV 2018-08-10
ReViral–Andera Partners: investment, 201808 financing round Series B totalling $55m incl existing + co-investor Andera Partners 2018-08-01
ReViral–EMS (BR): investment, 201808 financing round Series B totalling $55m incl existing + co-investor Brace Pharma Capital 2018-08-01
ReViral–OrbiMed Advisors: investment, 201808 financing round Series B totalling $55m incl existing + co-investor OrbiMed 2018-08-01
ReViral–SEVERAL: investment, 201808 financing round Series B $55m co-lead by new investors New Leaf Venture Partners + Novo Ventures 2018-08-01
Laboratorios Ecosur–Eurofins: investment, 201807 acquisition of Ecosur by Eurofins 2018-07-27
Nanobiotix–EU (govt): credit, 201807– up to €40m loan agreement with EIB over coming five years subjet to performance criteria 2018-07-26
Abivax–Kreos Capital: credit, 201807– debt financing up to €20m in 2 tranches with attached up to €1.6m warrants 2018-07-25
TxCell–Sangamo: investment, 201807– acquisiton $72m in cash on cash/debt-free basis with simplified cash tender offer 2018-07-23
Adocia–MC Services: public relations, 201807 service existent PR Europe by MC Services 2018-07-18
Adocia–Ruth Group: public relations, 201807 service existent IR USA by The Ruth Group 2018-07-18
Sanofi–Revolution Medicines: SHP2 inhibitors, 201807– collab ww to develop SHP2 inhibitors incl RMC-4630 for multiple cancers 2018-07-18
Sohin (MX)–HalioDx: cancer test, 201807– distribution of Immunoscore Colon Assay in Mexico by Sohin 2018-07-16
Antabio–SEVERAL: investment, 201807 2nd closing financing round Series A €5.2m bringing total Series A to €12.5m 2018-07-12
Institut Pasteur–Thermo Fisher: transmission electron microscope, 201807 supply Krios Cryo-TEM system to Institut Pasteur in Paris 2018-07-12
Miltenyi Biotec–Scienion: cell handling technology, 201807– collab co-marketing MACSQuant Tyto Cell Sorter with cellenONE X1 Cell Dispenser 2018-07-12
Omnes Capital–Brackendale Consulting: public relations, 201807 service existent by Brackendale Consulting 2018-07-12
Yposkesi–Andrew Lloyd Associates: public relations, 201807 service existent by ALA 2018-07-09
Dynacure–Andera Partners: investment, 201807 financing round totalling €47m incl lead investor Andera Partners 2018-07-06
Dynacure–France (govt): investment, 201807 financing round totalling €47m incl co-investor Bpifrance 2018-07-06
Dynacure–Idinvest Partners: investment, 201807 financing round totalling €47m incl co-investor Idinvest Partners 2018-07-06
Dynacure–Kurma: investment, 201807 financing round totalling €47m incl co-investor Kurma Partners 2018-07-06
Dynacure–Pontifax: investment, 201807 financing round totalling €47m incl co-investor Pontifax 2018-07-06
Dynacure–SEVERAL: investment, 201807 financing round €47m led by Andera Partners + incl Pontifax + Bpifrance + Kurma + IdInvest 2018-07-06
IMMUNOMONITOR project–Biomax: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–Enpicom: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–EU (govt): grant, 201807– Eurostars grant €2m to develop clin validation for treatm response to cancer vaccines 2018-07-05
IMMUNOMONITOR project–OSE Immunotherapeutics: pharmacogenomics, 201807– collab project partner develop validation treatm response cancer vaccines 2018-07-05
IMMUNOMONITOR project–Ultimovacs: pharmacogenomics, 201807– collab partner in Eurostars project to develop validation treatm response cancer vaccines 2018-07-05
IMMUNOMONITOR project–Univ Hamburg: pharmacogenomics, 201807– collab partner Eurostars in project develop validation treatm response cancer vaccines 2018-07-05
Netbiotix–Auriga: investment, 201807 financing round Series A totalling €7.5m incl lead investor Auriga Partners 2018-07-05
Netbiotix–Biocodex: investment, 201807 financing round Series A totalling €7.5m incl co-investor Biocodex 2018-07-05
Netbiotix–SEVERAL: investment, 201807 financing round Series A €7.5m led by Auriga Partners + incl Biocodex 2018-07-05
Nextbiotix–SEVERAL: investment, 201807 financing round Series A €7m led by Auriga Partners 2018-07-05
Nextbiotix–Ulysse Communication: public relations, 201807 service existent by Ulysse 2018-07-05
Laboratoire de Bromatologie de l’Ouest–Eurofins: investment, 201807 acquisition of LBO by Eurofins 2018-07-03
Pharma Omnium–NuPharm: investment, 201807 acquisition €na of Laboratoire Biodim from Pharma Omnium 2018-07-03
Hybiome (CN)–Mérieux: investment, 201807–201811 acquisition 54% shareholding in Suzhou Hybiome Biomedical Engineering Co Ltd by bioMérieux 2018-07-01
Mérieux–Deinove: antibiotics, 201806– collab antibotics drug discovery of bioMérieux + Deinove + AGIR project 2018-06-28
NodThera–5AM Ventures: investment, 201806 financing round Series A totalling £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
NodThera–Epidarex Capital: investment, 201806 financing round Series A totalling £28m ($40m) incl existing co-investor Epidarex Capital 2018-06-25
NodThera–F-Prime: investment, 201806 financing round Series A totalling £28m ($40m) incl co-investor F-Prime Capital Partners 2018-06-25
NodThera–Selvita: investment, 201806 existing investor 2018-06-25
NodThera–SEVERAL: investment, 201806 financing round Series A £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
NodThera–Sofinnova: investment, 201806 financing round Series A totalling £28m ($40m) co-led by Sofinnova Partners + 5AM Ventures 2018-06-25
Erytech–JMP Securities: investor conference, 201806 supply service Erytech presents at JMP Securities 2018 Life Sciences Conference NY 2018-06-20
Interactive Biosoftware–Sophia Genetics: investment, 201806 acquisition of IBS by Sophia Genetics 2018-06-16
Onxeo–Nice & Green: investment, 201806–201903 equity line financing up to €5.4m with up to 4.7new shares 2018-06-15
Sanofi–Evotec: investment, 201806–201807 acquisition integration of Sanofi’s infectious disease RnD in Lyon into Evotec 2018-06-15
Deinove–SEVERAL: investment, 201806 capital increase €8.5m with 3.148 new shares at €2.7/share 2018-06-14
Sartorius–Siemens: automation technology, 201806– collab long-term using Siemens automation for SSB’s bio production offerings 2018-06-12
Metafora Biosystems–EU (govt): grant, 201806– H2020 SME Instrument grant €3.2m for developm of blood test for early diagnosis of De Vivo disease 2018-06-11
Enyo Pharma–Andera Partners: investment, 201806 financing round Series B totalling €40m incl new + co-investor Andera Partners 2018-06-04
Enyo Pharma–France (govt): investment, 201806 financing round Series B totalling €40m incl Bpifrance Large Venture + InnoBio + ITI 2018-06-04
Enyo Pharma–Morningside: investment, 201806 financing round Series B totalling €40m incl existing investor Morningside Venture Investments 2018-06-04
Enyo Pharma–Orbimed Advisors: investment, 201806 financing round Series B totalling €40m incl new + lead investor OrbiMed Private Investment VII 2018-06-04
Enyo Pharma–SEVERAL: investment, 201806 financing round Series B €40m led by new investor OrbiMed + incl Andera Partners + Bpifrance et al 2018-06-04
Enyo Pharma–Sofinnova: investment, 201806 financing round Series B totalling €40m incl existing investor Sofinnova Private Capital VII 2018-06-04
TxCell–Lonza: cell therapy contract manufacturing, 201805– supply of TX200 for clinical studies by Lonza production site in Geleen (NL) 2018-05-31
Apix Analytics–DataApex: chromatography s/w, 201805– distribution Apix Analytics to market PixL Lab OEM version of Clarity s/w 2018-05-30
Voluntis–SEVERAL: investment, 201805 IPO €30.1m at Euronext Paris with 2.15m new shares at €14/share 2018-05-30
Sanofi–Adaptive Biotechnologies: pharmacogenomics, 2010805– collab €na use of NGS-based clonoSEQ Assay in multiple myeloma trials of isatuximab 2018-05-29
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page



Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 600x60px

» top